Innovation in the Delivery of Inhaled Nitric Oxide
VERO Biotech is a trailblazer in the life sciences sector, focusing on enhancing patient outcomes through cutting-edge technologies. Our flagship product, the GENOSYL® Delivery System (DS), epitomizes our commitment to innovation.
Learn more about GENOSYL DS at the 12th Annual CHOP Chronic Lung Disease Conference
March 10 – 11, 2026 | Philadelphia, PA
Clinician-Driven Innovation of Inhaled Nitric Oxide
See GENOSYL® DS in Action at our Booth
One Device For All Inhaled
Nitric Oxide (iNO) Needs
The only iNO device with approval for use in all areas of care, without requiring device changes.
News & Events
Keep up with VERO Biotech
VERO Biotech’s GENOSYL® Delivery System recognized as a “Technological Breakthrough” at Premier, I…
VERO Biotech’s Second Generation GENOSYL® Delivery System (DS) Receives FDA Approval in Anesthesia in …
VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric…
42nd Annual Children’s National Symposium
CHOP Chronic Lung Disease Conference
Cool Topics in Neonatology
Partnership365™ Service and Support
We’ll be there, because we’ve been there.
Partnership365™ connects customers with experienced respiratory therapists who are available 24/7/365 for training, troubleshooting and clinical support.
24/7/365 Expertise
Round-the-clock assistance from RTs with 10+ years of bedside experience.
Medical Information
Accurate, clinically relevant data for every medical request.
Inventory Management
Personalized monitoring and management of equipment and inventory.
Technical Support
Direct access to GENOSYL DS technical experts.
Training & Education
Comprehensive system onboarding and exclusive on-demand learning through the VERO Knowledge Center.
Contact us at 877.337.4118
Let’s Talk About Respiratory Care
Connect with the VERO team to learn how the GENOSYL® Delivery System supports clinicians with safer, more efficient inhaled nitric oxide therapy
Schedule a Demo
"*" indicates required fields